{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:57:14Z","timestamp":1762369034978,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jiac.2025.102680","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T20:01:32Z","timestamp":1742846492000},"page":"102680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of immunoprophylaxis for preterm infants of mothers having chronic hepatitis B virus infection: A retrospective study"],"prefix":"10.1016","volume":"31","author":[{"given":"Guanlun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxiu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minkai","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guorong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2025.102680_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.35","article-title":"Hepatitis B virus infection","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.jiac.2025.102680_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol; Hepatol"},{"issue":"5","key":"10.1016\/j.jiac.2025.102680_bib3","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/ije\/dyy077","article-title":"Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China","volume":"47","author":"Cui","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"Suppl 1","key":"10.1016\/j.jiac.2025.102680_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1478-3231.2008.01933.x","article-title":"Hepatitis B and pregnancy: an underestimated issue","volume":"29","author":"Jonas","year":"2009","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.jiac.2025.102680_bib5","first-page":"313","volume":"29","year":"2021","journal-title":"Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology"},{"issue":"1","key":"10.1016\/j.jiac.2025.102680_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR. Recommendations and reports : MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"issue":"5","key":"10.1016\/j.jiac.2025.102680_bib7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/ijp.ijp_881_20","article-title":"Pentaglobin (immunoglobulin M-enriched immunoglobulin) as adjuvant therapy for premature and very low-birth-weight neonates with sepsis","volume":"53","author":"Nassir","year":"2021","journal-title":"Indian J Pharmacol"},{"issue":"1","key":"10.1016\/j.jiac.2025.102680_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2020.1866950","article-title":"Vaccination in preterm and low birth weight infants in India","volume":"18","author":"Soans","year":"2022","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.jiac.2025.102680_bib9","article-title":"Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity","volume":"14","author":"Lu","year":"2023","journal-title":"Front Immunol"},{"issue":"5S","key":"10.1016\/j.jiac.2025.102680_bib10","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/INF.0000000000002773","article-title":"Factors that influence infant immunity and vaccine responses","volume":"40","author":"Zimmermann","year":"2021","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.jiac.2025.102680_bib11","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jhep.2011.02.032","article-title":"A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection","volume":"55","author":"Han","year":"2011","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jiac.2025.102680_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/hep.27034","article-title":"Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice","volume":"60","author":"Zhang","year":"2014","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"24","key":"10.1016\/j.jiac.2025.102680_bib13","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","article-title":"Tenofovir to prevent hepatitis B transmission in mothers with high viral load","volume":"374","author":"Pan","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jiac.2025.102680_bib14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/jvh.12670","article-title":"Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy","volume":"24","author":"Han","year":"2017","journal-title":"J Viral Hepat"},{"issue":"10","key":"10.1016\/j.jiac.2025.102680_bib15","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3390\/vaccines10101656","article-title":"Timing of the first dose of the hepatitis B vaccine in preterm infants","volume":"10","author":"Lei","year":"2022","journal-title":"Vaccines (Basel)"},{"year":"2017","series-title":"Global hepatitis report, 2017","key":"10.1016\/j.jiac.2025.102680_bib16"},{"issue":"4","key":"10.1016\/j.jiac.2025.102680_bib17","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.1016\/S2214-109X(22)00046-8","article-title":"Prevention of mother-to-child transmission of hepatitis B: birth-dose vaccination is not enough","volume":"10","author":"Noubiap","year":"2022","journal-title":"Lancet Global Health"},{"issue":"9","key":"10.1016\/j.jiac.2025.102680_bib18","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S2468-1253(18)30198-5","article-title":"Global prevalence of hepatitis B virus infection and prevention of mother-to-child transmission","volume":"3","author":"Xu","year":"2018","journal-title":"Lancet Gastroenterol; Hepatol"},{"issue":"49","key":"10.1016\/j.jiac.2025.102680_bib19","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1016\/j.vaccine.2016.03.045","article-title":"Preterm birth: case definition & guidelines for data collection, analysis, and presentation of immunisation safety data","volume":"34","author":"Quinn","year":"2016","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.jiac.2025.102680_bib20","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.arcped.2014.06.020","article-title":"[Is the new vaccination schedule recommended in France adapted to premature babies?]","volume":"21","author":"Gaudelus","year":"2014","journal-title":"Arch Pediatr : organe officiel de la Societe francaise de pediatrie"},{"issue":"6","key":"10.1016\/j.jiac.2025.102680_bib21","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4161\/hv.6.6.12008","article-title":"Impaired functioning of immune defenses to infection in premature and term infants and their implications for vaccination","volume":"6","author":"Baxter","year":"2010","journal-title":"Hum Vaccines"},{"issue":"31","key":"10.1016\/j.jiac.2025.102680_bib22","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.3748\/wjg.v28.i31.4249","article-title":"Insights into induction of the immune response by the hepatitis B vaccine","volume":"28","author":"Di Lello","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jiac.2025.102680_bib23","article-title":"Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21st standard: analysis of CHERG datasets","volume":"358","author":"Lee","year":"2017","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jiac.2025.102680_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12072-020-10055-9","article-title":"The prevalence of occult HBV infection in immunized children with HBsAg-positive parents: a hospital-based analysis","volume":"14","author":"Zhuge","year":"2020","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.jiac.2025.102680_bib25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12889-021-10211-2","article-title":"Breastfeeding practice in China from 2013 to 2018: a study from a national dynamic follow-up surveillance","volume":"21","author":"Kang","year":"2021","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.jiac.2025.102680_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/nu10020249","article-title":"Exclusive breastfeeding rate and complementary feeding indicators in China: a national representative Survey in 2013","volume":"10","author":"Duan","year":"2018","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.jiac.2025.102680_bib27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archpediatrics.2011.72","article-title":"Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review","volume":"165","author":"Shi","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jiac.2025.102680_bib28","article-title":"Distribution evaluation of tenofovir in the breast milk of mothers with HBeAg-positive chronic HBV infection after treatment with tenofovir alafenamide and tenofovir disoproxil fumarate by a sensitive UPLC-MS\/MS method","volume":"12","author":"Yang","year":"2021","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.jiac.2025.102680_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/cid\/ciu798","article-title":"Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence","volume":"60","author":"Ehrhardt","year":"2015","journal-title":"Clin Infect Dis : Off Publ Infect Dis Soc Am"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25000777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25000777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:49:59Z","timestamp":1762368599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25000777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1341321X25000777"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102680","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of immunoprophylaxis for preterm infants of mothers having chronic hepatitis B virus infection: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102680"}}